152 related articles for article (PubMed ID: 37864652)
1. Biphasic synovial sarcoma with myoepithelial features: a distinctive variant with a predilection for the foot.
Almohsen SS; Griffin AM; Dickson BC; Demicco EG
Virchows Arch; 2023 Oct; ():. PubMed ID: 37864652
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel SSX1 fusions in synovial sarcoma.
Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T
Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309
[TBL] [Abstract][Full Text] [Related]
3. Adamantinoma with a Prominent Spindle Cell Component Mimicking Intraosseous Synovial Sarcoma: Clinicopathological Features of Six Tumors.
Rekhi B; Yildiz AE; Jennifer A; Yukruk FA; Gedikoglu G; Banerjee D; Shetty O; Kosemehmetoglu K
Int J Surg Pathol; 2022 Dec; 30(8):872-884. PubMed ID: 35946120
[No Abstract] [Full Text] [Related]
4. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
[TBL] [Abstract][Full Text] [Related]
5. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
6. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
[TBL] [Abstract][Full Text] [Related]
7. Unusual mimicker of odontogenic carcinoma: Primary synovial sarcoma of the temporomandibular joint- a critical role for molecular diagnosis.
Bell D; Altan M; Gidley PW
Pathol Res Pract; 2022 Apr; 232():153824. PubMed ID: 35231858
[TBL] [Abstract][Full Text] [Related]
8. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
[TBL] [Abstract][Full Text] [Related]
9. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
10. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
11. Synovial sarcoma: defining features and diagnostic evolution.
Thway K; Fisher C
Ann Diagn Pathol; 2014 Dec; 18(6):369-80. PubMed ID: 25438927
[TBL] [Abstract][Full Text] [Related]
12. SYT-SSX fusion genes in synovial sarcoma of the thorax.
Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous myoepithelioma: a clinicopathologic and immunohistochemical study of 14 cases.
Hornick JL; Fletcher CD
Hum Pathol; 2004 Jan; 35(1):14-24. PubMed ID: 14745720
[TBL] [Abstract][Full Text] [Related]
14. Synovial sarcoma: ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors.
Fisher C
Hum Pathol; 1986 Oct; 17(10):996-1008. PubMed ID: 2428727
[TBL] [Abstract][Full Text] [Related]
15. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
16. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
[TBL] [Abstract][Full Text] [Related]
17. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
[TBL] [Abstract][Full Text] [Related]
18. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
[TBL] [Abstract][Full Text] [Related]
20. SS18-SSX Expression in a Contemporary Cohort of Primary Renal Synovial Sarcoma: A Multi-Institutional Experience of Fourteen Patients.
Challa B; Mohanty SK; Jha S; Sampat NY; Sardana R; Lobo A; Sharma S; Arora S; Rath D; Munjal G; Pattnaik N; Jain D; Jain E; Dewan A; Dixit M; Malik V; Shinde S; Balzer BL; Parwani A
Int J Surg Pathol; 2023 Oct; 31(7):1232-1243. PubMed ID: 36591871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
